Manji Husseini 4

What Happened
Manji Husseini, a director of Alto Neuroscience (ANRO), was granted a derivative award covering 10,958 shares on May 12, 2026. The award shows a $0.00 acquisition price (no cash paid) and is reported as a derivative security (an option-style award rather than an immediate share purchase). This is a compensation grant to a non-employee director, not a sale or open-market purchase.

Key Details

• Transaction date: 2026-05-12; reported on Form 4 filed 2026-05-14 (timely within the usual two-business-day window).
• Consideration: $0.00 (the reporting person did not pay any cash for the derivative securities).
• Shares/units granted: 10,958 (derivative/option-style award).
• Shares owned after transaction: not disclosed in this Form 4.
• Footnotes:
  • Vesting: award vests on the earlier of the one-year anniversary of grant and the issuer’s next annual meeting, subject to continuous service.
  • Award issued under the Issuer’s Non-Employee Director Compensation Policy and was not purchased by the director.
• Transaction type: A = Award/Grant (derivative).

Context
Director grants like this are common as part of non-employee director compensation and do not represent an immediate cash investment or sale by the insider. Because these are derivative awards with vesting, future filings may follow when vesting occurs or if/when options are exercised or shares are delivered. Such grants are routine compensation and should be interpreted differently from outright purchases (which can signal a direct stake-building by insiders).